Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

Mild-to-Moderate Gestational Iodine Deficiency Processing Disorder.

Hay I, Hynes KL, Burgess JR.

Nutrients. 2019 Aug 22;11(9). pii: E1974. doi: 10.3390/nu11091974.

3.

Management of Papillary Thyroid Microcarcinoma.

Brito JP, Hay ID.

Endocrinol Metab Clin North Am. 2019 Mar;48(1):199-213. doi: 10.1016/j.ecl.2018.10.006. Epub 2018 Dec 23. Review.

PMID:
30717902
5.

Papillary Thyroid Carcinoma (PTC) in Children and Adults: Comparison of Initial Presentation and Long-Term Postoperative Outcome in 4432 Patients Consecutively Treated at the Mayo Clinic During Eight Decades (1936-2015).

Hay ID, Johnson TR, Kaggal S, Reinalda MS, Iniguez-Ariza NM, Grant CS, Pittock ST, Thompson GB.

World J Surg. 2018 Feb;42(2):329-342. doi: 10.1007/s00268-017-4279-x.

PMID:
29030676
6.

Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer.

Prasongsook N, Kumar A, Chintakuntlawar AV, Foote RL, Kasperbauer J, Molina J, Garces Y, Ma D, Wittich MAN, Rubin J, Richardson R, Morris J, Hay I, Fatourechi V, McIver B, Ryder M, Thompson G, Grant C, Richards M, Sebo TJ, Rivera M, Suman V, Jenkins SM, Smallridge RC, Bible KC.

J Clin Endocrinol Metab. 2017 Dec 1;102(12):4506-4514. doi: 10.1210/jc.2017-01180.

PMID:
29029287
7.

Thyroid cancer: Overdiagnosis of papillary carcinoma - who benefits?

Brito JP, Hay ID.

Nat Rev Endocrinol. 2017 Mar;13(3):131-132. doi: 10.1038/nrendo.2016.224. Epub 2017 Jan 6. No abstract available.

PMID:
28059158
8.

Minimal extrathyroid extension in papillary thyroid carcinoma does not result in increased rates of either cause-specific mortality or postoperative tumor recurrence.

Hay ID, Johnson TR, Thompson GB, Sebo TJ, Reinalda MS.

Surgery. 2016 Jan;159(1):11-9. doi: 10.1016/j.surg.2015.05.046. Epub 2015 Oct 26.

PMID:
26514317
9.

The Impact of Subclinical Disease and Mechanism of Detection on the Rise in Thyroid Cancer Incidence: A Population-Based Study in Olmsted County, Minnesota During 1935 Through 2012.

Brito JP, Al Nofal A, Montori VM, Hay ID, Morris JC.

Thyroid. 2015 Sep;25(9):999-1007. doi: 10.1089/thy.2014.0594. Epub 2015 Jul 30.

10.

Most patients with a small papillary thyroid carcinoma enjoy an excellent prognosis and may be managed with minimally invasive therapy or active surveillance.

Castro MR, Morris JC, Ryder M, Brito JP, Hay ID.

Cancer. 2015 Sep 15;121(18):3364-5. doi: 10.1002/cncr.29468. Epub 2015 Jun 16. No abstract available.

11.

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.

Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S; American Thyroid Association Guidelines Task Force.

Thyroid. 2015 Jul;25(7):716-59. doi: 10.1089/thy.2014.0460. Review.

12.

Follicular cell-derived thyroid cancer.

Dralle H, Machens A, Basa J, Fatourechi V, Franceschi S, Hay ID, Nikiforov YE, Pacini F, Pasieka JL, Sherman SI.

Nat Rev Dis Primers. 2015 Dec 10;1:15077. doi: 10.1038/nrdp.2015.77. Review.

PMID:
27188261
13.

Clinical and molecular features of Hürthle cell carcinoma of the thyroid.

Chindris AM, Casler JD, Bernet VJ, Rivera M, Thomas C, Kachergus JM, Necela BM, Hay ID, Westphal SA, Grant CS, Thompson GB, Schlinkert RT, Thompson EA, Smallridge RC.

J Clin Endocrinol Metab. 2015 Jan;100(1):55-62. doi: 10.1210/jc.2014-1634.

PMID:
25259908
14.

Low risk papillary thyroid cancer.

Brito JP, Hay ID, Morris JC.

BMJ. 2014 Jun 16;348:g3045. doi: 10.1136/bmj.g3045. Review.

PMID:
24935445
15.

A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H.

Bible KC, Suman VJ, Molina JR, Smallridge RC, Maples WJ, Menefee ME, Rubin J, Karlin N, Sideras K, Morris JC 3rd, McIver B, Hay I, Fatourechi V, Burton JK, Webster KP, Bieber C, Traynor AM, Flynn PJ, Cher Goh B, Isham CR, Harris P, Erlichman C; Endocrine Malignancies Disease Oriented Group, Mayo Clinic Cancer Center, and the Mayo Phase 2 Consortium.

J Clin Endocrinol Metab. 2014 May;99(5):1687-93. doi: 10.1210/jc.2013-3713. Epub 2014 Feb 25.

16.

Reoperative experience with papillary thyroid cancer.

Onkendi EO, McKenzie TJ, Richards ML, Farley DR, Thompson GB, Kasperbauer JL, Hay ID, Grant CS.

World J Surg. 2014 Mar;38(3):645-52. doi: 10.1007/s00268-013-2379-9.

PMID:
24305931
17.

Long-term outcome of ultrasound-guided percutaneous ethanol ablation of selected "recurrent" neck nodal metastases in 25 patients with TNM stages III or IVA papillary thyroid carcinoma previously treated by surgery and 131I therapy.

Hay ID, Lee RA, Davidge-Pitts C, Reading CC, Charboneau JW.

Surgery. 2013 Dec;154(6):1448-54; discussion 1454-5. doi: 10.1016/j.surg.2013.07.007. Epub 2013 Oct 28.

PMID:
24176579
18.

Mild iodine deficiency during pregnancy is associated with reduced educational outcomes in the offspring: 9-year follow-up of the gestational iodine cohort.

Hynes KL, Otahal P, Hay I, Burgess JR.

J Clin Endocrinol Metab. 2013 May;98(5):1954-62. doi: 10.1210/jc.2012-4249. Epub 2013 Apr 30.

PMID:
23633204
19.

Interoperability for device manufacturers: building a personal, connected health ecosystem.

Hay I, Lim K, Wartena F.

Biomed Instrum Technol. 2012 Fall;Suppl:71-7. doi: 10.2345/0899-8205-46.s2.71. No abstract available.

PMID:
23039780
20.

Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers.

Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C.

J Oncol Pract. 2012 May;8(3 Suppl):e1s-5s. doi: 10.1200/JOP.2011.000496.

Supplemental Content

Loading ...
Support Center